Drug approval packages and briefing documents are already freely availableBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4861 (Published 13 August 2013) Cite this as: BMJ 2013;347:f4861
- Larry D Sasich, consultant pharmacist1,
- Elia Abi-Jaoude, research fellow2
- 1839 Main Street West #3, North Bay, ON, Canada P1B 2V8
- 2Department of Psychiatry, University of Toronto, Toronto, ON, Canada
Goldacre lists four levels of clinical trial transparency, three of which are priorities for the AllTrials campaign.1 The first three of these priorities have been freely available for years for drugs approved or discussed by advisory committees in the US, yet these documents are rarely used.
These documents are prepared by scientists from the US Food and …